Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BGN Technologies
Beer Sheva, Israelbgn.bgu.ac.il ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
BGN Technologies acts as Ben-Gurion University's tech transfer company, linking academia with industry, commercializing hundreds of patents including those for new cancer therapeutics, anti-biofilm agents, and enabling technologies for cell anomaly detection; most programs are at the invention or startup stage, not direct clinical results[1][2][3][4][7].
- Therapeutic areas
- OncologyInfectious DiseasesOther
- Modalities
- Small moleculeAntisense oligonucleotideProteinRecombinant proteinNanoparticle
- Industry
- Drug Discovery Services
02
Partnerships
Sorrento Therapeutics[6]William Marsh Rice University[7]Regents of University of Minnesota[7]Nanyang University[7]GM Global Technology Operations LLC[7]University of Connecticut[7]
Beyond the preview
Go deeper on BGN Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BGN Technologies.